We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Bring photo ID to vote Check what photo ID you'll need to vote in person in the General Election on 4 July.
Teva UK Limited has informed the MHRA that it plans to withdraw from further sale all batches of GoResp Digihaler (budesonide and formoterol fumarate dihydrate) and the linked Digihaler App for commercial reasons.
This document contains the following information: Government response to the Health Committee's report on patient and public involvement in the NHS.
First published during the 2005 to 2010 Labour government
Neuraxpharm UK Ltd is recalling specific batches after retesting showed out of specification results. The tabled batches are being recalled as a precautionary measure after testing showed variability of the capsule contents beyond permitted levels.
The survey is conducted on an annual basis and includes all adult patients (aged 16 and over), with a confirmed primary diagnosis of cancer, who have been admitted to hospital as inpatients for cancer related treatment, or who were seen...
Sets out the Patient Reference Group’s reflections on the recommendations in the Independent Medicines and Medical Devices Safety (IMMDS) Review report.
A patient alert card is being introduced for men taking finasteride to help raise awareness of the risk of psychiatric side effects and sexual dysfunction, including the potential for sexual dysfunction to persist after treatment has stopped. Healthcare professionals are...
Follow-up surveys for users of the NHS 111 / Integrated Urgent Care service
The CMA has completed its remittal into the private healthcare market and has brought article 22 of the 2014 Order into force.
The GP Patient Survey assesses patients’ experience of healthcare services provided by GP surgeries and experience of NHS dental services.
NHS England publishes the 2017 National Cancer Patient Experience Survey (CPES). The national results will provide an up to date overview of cancer patient experience across England. The survey is conducted by Quality Health on behalf of NHS England. The...
The GP Patient Survey assesses patients’ experience of healthcare services provided by GP practices and experience of NHS dental services.
The National Cancer Patient Experience Survey covers all 148 acute and specialist NHS Trusts in England that provide adult acute cancer services.
The GP Patient Survey assesses patients’ experiences of healthcare services provided by GP practices and experience of NHS dental services. The results are presented at GP practice, Clinical Commissioning Group (CCG), and national level.
NHS England publishes the 2023 National Cancer Patient Experience Survey (CPES). The Cancer Patient Experience Survey has been designed to monitor national progress on cancer care; to provide information to drive local quality improvements; to assist commissioners and providers of...
Statistics on children and young people’s experiences of admitted NHS hospital care in England in November 2020, December 2020 and January 2021.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).